Gastric cancer (GC) represents the third leading cause of
cancer-related deaths worldwide. The levels of
prostaglandin E2, a key player in the hallmarks of
cancer, are mainly regulated by
prostaglandin-endoperoxide synthase 2 (
PTGS2) and
ATP-binding cassette subfamily C member 4 (ABCC4), involved in its synthesis and exportation, respectively, and
15-hydroxyprostaglandin dehydrogenase (15-PGDH) and solute carrier
organic anion transporter family member 2A1 (SLCO2A1), responsible for its inactivation. Even though there are distinct molecular signatures across ethnic populations, most published studies focus on Asian populations. Our main aim was to explore the genetic expression of the aforementioned molecules in a Caucasian population. 94 "Normal" and 89 tumoral
formalin-fixed
paraffin-embedded (FFPE) samples from GC patients were used to assess the
mRNA expression of
PTGS2, ABCC4,
hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD), SLCO2A1 by Real-Time PCR. We found an upregulation for the
PTGS2 gene mean factor of 2.51 and a downregulation for the HPGD and SLCO2A1 genes (mean factor of 0.10 and 0.37, respectively) in tumorous mucosa in a gender-independent manner. In females, we observed an ABCC4 downregulation and a
PTGS2 mRNA upregulation compared to males in tumoral mucosa (mean factor of 0.61 and 1.64, respectively). We reported dysregulation of the
inflammation triggered
PGE2 pathway in a Caucasian population with an intermediate risk for GC, which might highlight the applicability of
aspirin in the treatment of GC patients.